Maintenance of activated astroglial cell status (astrogliosis) following nervous system injury. GFAP protein and its breakdown products are rapidly released into biofluids, making them strong candidate biomarkers for such neurological disorders. The gene discussed is GFAP; the disease is nervous system disorder.